Expansion Technologies Overview
- Founded
-
2015
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$1.5M
- Investors
-
1
Expansion Technologies General Information
Description
Developer of a 3D imaging detection device designed to revolutionize the early detection of diseases. The company's device physically expands samples, coupled with multiplexed in-situ analysis methods and machine learning, enabling physicians to develop drugs for specific needs.
Contact Information
Website
www.extbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Diagnostic Equipment
Primary Office
- One Kendall Square
- Cambridge, MA 02139
- United States
+1 (617) 000-0000
Expansion Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 13-Nov-2017 | $1.5M | 00.00 | 00.00 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | 26-Feb-2016 | 000 | 000 | 000 | Completed | Generating Revenue |
Expansion Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 00.000 |
Expansion Technologies Patents
Expansion Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220074827-A1 | Expansion microscopy compatible anchorable h&e staining for histopathology | Pending | 31-Dec-2018 | 00000000 | |
| US-20200354782-A1 | Expansion microscopy compatible and multiplexed in situ hybridization of formalin fixed paraffin embedded tissue sections for spatially resolved transcriptomics | Pending | 21-Nov-2017 | 0000000000 | |
| US-20200239946-A1 | Multiplexed in situ hybridization of tissue sections for spatially resolved transcriptomics with expansion microscopy | Pending | 11-Oct-2017 | 0000000000 | |
| US-20210215580-A1 | Combining modified antibodies with expansion microscopy for in-situ, spatially-resolved proteomics | Pending | 11-May-2016 | 00000000 | |
| US-20180052081-A1 | Combining modified antibodies with expansion microscopy for in-situ, spatially-resolved proteomics | Abandoned | 11-May-2016 | G01N1/30 |
Expansion Technologies Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Edward Boyden Ph.D | Co-Founder & Board Member | ||
| Jeremy Wertheimer Ph.D | Co-Founder |
Expansion Technologies Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Edward Boyden Ph.D | Self | Co-Founder & Board Member | 000 0000 |
| Oded Kadosh | Expansion Technologies | Board Member | 000 0000 |
| Tamar Erdfarb | Expansion Technologies | Board Member | 000 0000 |
Expansion Technologies Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Expansion Technologies Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Biological Engineering Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |